Therefore, we have reason to believe that the high expression of SIGLEC7 in the mesenchymal subtype of glioma could serve as one of the indicators for diagnosing the mesenchymal subtype of glioma. This evidence concerns the gene SIGLEC7 and central nervous system cancer.